A patient develops increasing dyspnea and hypoxemia 2 days after heart surgery. What procedure should the nurse anticipate assisting with to determine whether the patient has acute respiratory distress syndrome (ARDS) or pulmonary edema caused by heart failure?

B. Right-sided heart failure leads to congestion of the systemic venous circulation, resulting in increased central venous pressure (CVP). Elevated CVP is a hallmark sign of right-sided heart failure and is often used clinically to assess right ventricular preload and volume status.

A. BNP is a hormone secreted by the heart in response to increased ventricular stretch and volume overload, and its levels are usually elevated in heart failure, including both left-sided and right-sided heart failure.

C. Specific gravity refers to the concentration of solutes in urine and is often used as a measure of urine concentration.

D. Pulmonary artery wedge pressure (PAWP) is a measure of left atrial pressure and left ventricular end- diastolic pressure. In right-sided heart failure, the primary hemodynamic abnormality is congestion of the systemic venous circulation, rather than elevated left-sided pressures.

C. Amiodarone is a Class III antiarrhythmic medication commonly used for the acute management of atrial fibrillation with a rapid ventricular rate. It works by blocking multiple ion channels, prolonging the action potential duration, and slowing conduction in the atria and ventricles. Amiodarone is often used when other interventions such as vagal maneuvers or beta blockers are ineffective or contraindicated. In this scenario, where the patient is hypotensive and symptomatic, intravenous amiodarone may be administered to control the ventricular rate and stabilize hemodynamics

A. Bearing down, or the Valsalva maneuver, is a vagal maneuver that can sometimes help slow the heart rate in certain arrhythmias by increasing parasympathetic tone. However, it may not be effective or safe in all situations, especially if the patient is hypotensive or confused. In this scenario, immediate pharmacological intervention is likely needed to control the heart rate and stabilize hemodynamics.

B. Lidocaine is not typically used to treat atrial fibrillation with a rapid ventricular rate. Lidocaine is a Class IB antiarrhythmic medication primarily used for the treatment of ventricular arrhythmias, such as ventricular tachycardia and ventricular fibrillation. It is not considered a first-line agent for atrial fibrillation and may not effectively control the ventricular rate in this situation.

D. While beta blockers are commonly used for rate control in atrial fibrillation, they may not be the best choice in this scenario where the patient is hypotensive and symptomatic. Beta blockers can further decrease blood pressure and exacerbate hypotension, especially in patients with compromised hemodynamics. In such cases, other rate-controlling agents like calcium channel blockers or amiodarone may be preferred.